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Abstract
Background: Electroporation-based gene therapy and DNA vaccination are
promising medical applications that depend on transfer of pDNA into target tissues
with use of electric pulses. Gene electrotransfer efficiency depends on electrode
configuration and electric pulse parameters, which determine the electric field
distribution. Numerical modeling represents a fast and convenient method for
optimization of gene electrotransfer parameters. We used numerical modeling,
parameterization and numerical optimization to determine the optimum parameters
for gene electrotransfer in muscle tissue.
Methods: We built a 3D geometry of muscle tissue with two or six needle
electrodes (two rows of three needle electrodes) inserted. We performed a
parametric study and optimization based on a genetic algorithm to analyze the
effects of distances between the electrodes, depth of insertion, orientation of
electrodes with respect to muscle fibers and applied voltage on the electric field
distribution. The quality of solutions were evaluated in terms of volumes of reversibly
(desired) and irreversibly (undesired) electroporated muscle tissue and total electric
current through the tissue.
Results: Large volumes of reversibly electroporated muscle with relatively little
damage can be achieved by using large distances between electrodes and large
electrode insertion depths. Orienting the electrodes perpendicular to muscle fibers is
significantly better than the parallel orientation for six needle electrodes, while for
two electrodes the effect of orientation is not so pronounced. For each set of
geometrical parameters, the window of optimal voltages is quite narrow, with lower
voltages resulting in low volumes of reversibly electroporated tissue and higher
voltages in high volumes of irreversibly electroporated tissue. Furthermore, we
determined which applied voltages are needed to achieve the optimal field
distribution for different distances between electrodes.
Conclusion: The presented numerical study of gene electrotransfer is the first that
demonstrates optimization of parameters for gene electrotransfer on tissue level. Our
method of modeling and optimization is generic and can be applied to different
electrode configurations, pulsing protocols and different tissues. Such numerical
models, together with knowledge of tissue properties can provide useful guidelines
for researchers and physicians in selecting optimal parameters for in vivo gene
electrotransfer, thus reducing the number of animals used in studies of gene therapy
and DNA vaccination.
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In the last decades advances in genetic research offered a set of new therapies for var-
ious diseases based on in vivo genetic manipulations. The most developed of them are
gene therapy and DNA vaccination, which have already been tested in several clinical
trials [1-4]. While gene therapy works by delivering therapeutic genes into target cells
to express themselves and produce proteins acting directly against a given disease, in
genetic vaccination the produced proteins act as antigens that illicit an immune
response [5,6]. In the future, genetic therapies could represent an effective treatment
for degenerative diseases, cancer, infections and cardiovascular diseases, for which cur-
rently no adequate treatments are available [3,7-10].
The first step for gene therapy and DNA vaccination is efficient transfer of DNA
molecules into target cells. In vitro, chemical, physical and biological methods have
been successfully used for gene transfer [7,11,12]. However, there have been difficulties
of translating these methods into in vivo settings. Currently, viral vectors boast the
highest transfection efficiency, but this efficiency comes with an increased risk of viral
infection [13,14]. Therefore, alternative methods are being developed. One of the most
promising physical methods for gene transfer in vivo is gene electrotransfer which, in
comparison to viral vectors, is not hampered in terms of immunogenicity or patho-
genicity. Gene electrotransfer combines the use of pDNA and local application of elec-
tric pulses, which increase the permeability of target cells (electroporation) for
different molecules, including pDNA, and thus enable transfer of DNA into the cell.
Compared to other physical and chemical methods, it was shown that gene electro-
transfer is the most versatile and also the most efficient method in vivo compared to
other methods. For example, the gene gun method is limited to exposed tissues while
complexes of DNA and cationic lipids or polymers can be unstable, inflammatory and
toxic [7]. Gene electrotransfer has therefore great potential to be used in clinics for
treatment of cancer and various chronic diseases [15-22], and also for DNA vaccina-
tion for prevention of various infectious diseases and HIV [6]. Moreover, recently it
was demonstrated that gene electrotransfer can be successfully applied as a method for
DNA vaccination for cancer treatment [6,23,24], where DNA for a certain tumor anti-
gen is transferred during remission and can thus prepare the immune system for a bet-
ter response against the tumor cells during relapse of the disease.
Gene electrotransfer was demonstrated almost 30 years ago [25] when it was first
shown that exposing cells to high-voltage electric pulses results in transfer of DNA
molecules and expression of the delivered genes. Up to now, several steps that are
involved in gene electrotransfer have been identified: electropermeabilization of the cell
membrane, contact of pDNA with the cell membrane (formation of a DNA-membrane
complex), translocation of pDNA across the membrane, transfer of pDNA to and into
the nucleus and gene expression [26-29]. The effectiveness of electroporation and con-
sequently of gene electrotransfer depends on pulse parameters, such as amplitude,
duration, number, pulse repetition frequency and geometric properties of electrode
and tissue/sample configuration [30-33]. These parameters define the duration of expo-
sure to external electric field and the electric field strength, which have been shown to
be the most important parameters in cell electroporation. Namely, molecular transport
into and out of cells is observed only above a threshold value for reversible electro-
poration E>E rev. When electric field is further increased above the irreversible
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changes in the cell membrane become irreversible and cells die. Therefore for efficient
gene electrotransfer it is crucial to choose an appropriate applied voltage/electrode
configuration, such that the local electric field in the target tissue is between the rever-
sible and irreversible electroporation threshold Erev >E>E irr, which enables gene
transfer and preserves cell viability, thus enabling successful gene expression.
Gene electrotransfer was first demonstrated in vivo in 1998 by several independent
studies [34-37]. It is currently being extensively studied on animal models in vivo for
gene therapy [7,16,19,30,38,39] as well as DNA vaccination [6,23,40]. In the last years
the first human clinical trials have also started and also show encouraging results
[18,19,41-43]. One of the major obstacles towards translating gene electrotransfer into
clinical applications is its relatively low efficiency. Even though it was demonstrated
that in skin [39,44-50] and muscle tissue [34,37,51-56] prolonged expression of trans-
fected genes can be achieved, the relative transfection rates have remained relatively
low. In order to improve transfection efficiency the parameters of electric pulses have
to be optimized depending on the type of electrodes used and specifically adjusted for
each target tissue (e.g. muscle, skin, tumor tissue).
Several researchers have demonstrated that numerical modeling can be used to pre-
dict the extent of electroporation in biological tissues [57-64]. Also, numerical model-
ing and optimization have already been used for optimization of electric pulse
parameters for electrochemotherapy of subcutaneous tumors, for tumor ablation with
irreversible electroporation [63,65-67] and recently, the first deep-seated tumor was
treated with electrochemotherapy based on a numerical treatment plan [68]. However,
up to now there exists no such study which would use numerical modeling for optimi-
zation of gene electrotransfer.
In our present study we used 3D numerical modeling and numerical optimization to
determine the best electrical parameters for efficient gene electrotransfer into muscle
tissue, which is regarded by many as the “tissue of choice” for gene electrotransfer-
based gene therapy and DNA vaccination [19,30,41,69,70]. We performed a parametric
study to better understand how various electroporation parameters (applied voltage,
number of electrodes used, electrode positions, insertion depth) affect the electric field
distribution in muscle tissue, and numerical optimization of the parameters to demon-
strate that such numerical “treatment planning” could be used by researchers and clini-
cians to better control the extent of electroporation in the target tissues. We compared
different needle electrode configurations recommended in the literature for gene elec-
trotransfer in large animals and humans and analyzed the effect of orientation of the
electrodes (and thus the electric field) with respect to the orientation of muscle fibers.
The methods used in this study and the obtained results can be used as guidelines for
future numerical studies and planning of gene electrotransfer in vivo.
Methods
Model geometry and tissue properties
The numerical model of electroporation used in our study was similar to the one used
by Corovic et al for modeling electroporation of muscle tissue in small animals [71]. In
short, muscle tissue geometry was modeled as a block of size 10 × 10 × 6 cm in the
direction of the X, Y and Z axis, respectively (Figure 1), with the long axis of the muscle
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muscle and at the same time represents a sufficiently large computational domain to
avoid any significant numerical errors due to boundary conditions. Two different needle
electrode configurations were used in our model: two needle electrodes and six needle
electrodes arranged into two rows of three electrodes (Figure 1). The needle electrodes
were modeled as 5 cm long stainless steel cylinders with diameters of 0.7 mm.
The muscle tissue was considered anisotropic, with higher conductivity in the direc-
tion parallel to muscle fibers (s
1
xx = 0.75 S/m; s
2
xx = 2.0 S/m) than in the perpendicu-
lar direction (s
1
yy = s
1
zz =0 . 1 3 5S / m ;s
2
yy = s
2
zz = 0.54 S/m). Index
1 denotes initial
values prior to electroporation, while index
2 denotes the maximum achieved conduc-
tivities in the model (after irreversible electroporation is achieved in the tissue) [72].
The reversible electroporation threshold values for muscle tissue were taken to be 80
V/cm and 200 V/cm for electric field parallel and perpendicular to muscle fiber orien-
tation, respectively, while the irreversible threshold was taken to be 450 V/cm irrespec-
tive of electric field direction. These values were selected considering both our
previous studies of in vivo electroporation studies [71,73], where the thresholds were
measured for 8 × 100 μs electric pulses, and the measurements of muscle tissue con-
ductivity found in the available literature [74]. The importance of using anisotropic tis-
sue properties instead of isotropic properties is illustrated in Figure 2, where the
difference in electric field distribution between both cases is clearly seen.
Numerical modeling
The numerical models were designed in Comsol Multiphysics 3.5a (Comsol AB,
Sweden) and solved with the finite element method on a desktop PC (Windows 7 64-
bit, Intel Core 2 Duo 2.66 GHz, 4 GB RAM). The electric field distribution was deter-
mined by solving the Laplace equation for static electric currents:
∇− ∇ () () =  u 0, (1)
where s is the tensor of electrical conductivity and u the electric potential. The
boundary conditions used in our calculations were: 1) constant potential on the surface
Figure 1 Model geometry with muscle tissue (pink) and needle electrodes (blue).
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of the model.
As the parametric study and optimization d e s c r i b e di nt h en e x ts e c t i o ni n v o l v e d
moving and rotating the electrodes with respect to the muscle tissue and thus repeated
meshing of the model geometry, some of the meshing could be avoided by rotating the
tissue properties (thus virtually rotating the muscle tissue) instead of the electrodes.
The final form of the conductivity used in the models is therefore given by a tensor:

     
     =
+−
−
xx yy xx yy
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(2)
Since tissue properties are known to change during electroporation [72,75,76], each
component (sxx and syy = szz) of electrical conductivity was modeled as an electric
field-dependent function s(E):


 E
EE
E
irr rev
() =
−
−
+ 21
1 ·, (3)
where s1 and s2 are tensors of electrical conductivities of non-electroporated and
electroporated tissues, respectively (see previous section), and Eirr and Erev are the
thresholds of irreversible and reversible electroporation, respectively. We approximated
the dynamics of the conductivity changes during electroporation by performing several
sequential calculation of the electric field distribution, while changing the conductiv-
ities according to Eq. 3. The details of the sequential analysis can be found in our pre-
vious work [57,73].
The results of the numerical modeling were analyzed by calculating the volumes for
reversibly and irreversibly electroporated muscle tissue, Vrev and Virr, respectively, and
total current through the tissue I. Vrev was calculated by integrating the volume of
muscle tissue, where conductivity has changed (sxx, syy or szz), while Virr by integrat-
ing the volume, where the electric field was over the irreversible electroporation
threshold E>E irr.
Figure 2 Electric field distribution for isotropic and anisotropic muscle conductivity. Electric field
distribution for six needle electrodes (white circles) with a) isotropic tissue and b) anisotropic tissue
properties is shown. Electric field between 80 V/cm and 450 V/cm are presented in colors from blue to red,
while fields over 450 V/cm are presented in dark brown (around the electrodes).
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To determine the best electrode positions and voltages between electrodes for gene elec-
trotransfer into muscle tissue several geometrical and electrical parameters were ana-
lyzed in a parametric study. Bound constraints for each parameter and discretization
steps were chosen as following: distance between electrodes of different polarity - d (4
mm and 8-56 mm, 8 mm step); distance between electrodes of the same polarity - b (4-
28 mm, step of 4 mm); depth of electrode insertion - z (10-40 mm; 10 mm step); angle
between the electric field and muscle fiber orientation - j (0-90°; 22.5° steps) and voltage
between the electrodes - U (400-2400 V, 200 V step for six electrodes; 600-3000 V for
two electrodes) (Figure 3). Altogether 12,320 calculations were performed for six elec-
trodes and 2,080 for two electrodes. The ranges of geometric parameters were selected
to scale from typical dimensions used for gene electrotransfer in small animals to dimen-
sion applicable to large animals and humans. Results were controlled for numerical
errors by increasing the size of our model domain and increasing the mesh density, until
error due to domain size and due to meshing irregularities were insignificant–af u r t h e r
increase in domain size or mesh density only increased the computation time; however,
the results (Vrev, Virr) changed less than 2%. The quality of solutions for given sets of
parameters was evaluated by calculating the volume of muscle tissue that was reversibly
but not irreversibly electroporated, and the electric currents flowing through the model,
as presented in the objective function:
F
VI
VV
irr
rev irr
=
>> ()
−
⎧
⎨
⎪
⎩ ⎪
⎫
⎬
⎪
⎭ ⎪
01 3 0
3 ,|
.
,
if cm A
otherwise
(4)
The limit value for Virr (1 cm
3) was based on our estimate of tissue damage pro-
duced by electrode insertion and the fact th a ts o m et i s s u ed a m a g ei sa l w a y sp r e s e n t
around needle electrodes during electroporation. The limit value for I (30 A) was
based on the limitation of electroporation devices available on the market at the time
of the study. By taking into account constraints for Virr and for I, extensive damage to
Figure 3 Geometrical and electrical parameters analyzed in the parametric and optimization study.
Two electrodes and six electrodes in muscle tissue in A) the XY plane and B) the XZ plane are shown. The
following parameters were optimized: d (4 mm and 8-56 mm, 8 mm step); b (4-28 mm, step of 4 mm);
z (10-40 mm; 10 mm step); j (0-90 °; 22.5° steps) and U (400-2400 V, 200 V step for six electrodes; 600-3000
V for two electrodes). Note that j = 0° is referred to in the text as the parallel orientation, while j = 90° is
referred to as the perpendicular orientation.
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guaranteed.
Optimization
The same parameters (distances between electrodes, depth of insertion, voltage
between electrodes) and the same objective function used in the parametric study were
also used in the optimization, only the steps were smaller: d - 2 mm, b -2m m ,z -5
mm, j - 10° and U - 100 V. For the optimization we used a genetic algorithm that has
been described in detail in our previous work [66]. In short, the genetic algorithm was
written in MATLAB 2007a (Mathworks, USA) and run together with the numerical
calculation using the link between MATLAB and COMSOL. The initial population of
chromosomes (vectors of real numbers - one for each optimized parameter) was gener-
ated randomly, taking into account the bound constraints. In each iteration, the chro-
mosomes were selected for reproduction with a probability proportional to the values
of their objective function. The selected chromosomes reproduced by mathematical
operations of crossover (5) or mutation (6):
za x a ya ii i i ii =+ − () ∈[] ·, , , 10 1 (5)
mxb xb iii ii =+ ∈ − [] ·, .,. , 0303 (6)
where zi and mi are child chromosomes, xi and yi are parent chromosomes and ai
and bi are numbers randomly chosen from the given intervals. The optimization was
stopped after the chromosome with the highest objective function value has not
improved in 20 iterations for more than 0.1%, which was interpreted as reaching a
solution very close to the global optimum.
Results
Parametric study
The parametric study produced a vast number of different solutions of electric field dis-
tribution (2,080 for two needle electrodes and 12,320 for six needle electrodes), which
were analyzed by calculating the volumes of reversibly and irreversibly electroporated
tissue, and the objective function value (Eq. 4). Figures 4, 5, 6 and 7 show the optimal of
these solutions (highest F) for each given value of the analyzed parameter, while all the
other parameters change according to the selected bounds and steps (Figure 3). E.g., in
Figure 4a for each value of distance between electrodes d, all the other parameters (z, j,
U) are varied and the optimal solution (highest F) is presented at given d.
Two needle electrodes
For two needle electrodes, increasing the distance between the electrodes (d) produces
higher values of the objective function up to d = 48 mm, however to achieve this,
higher voltages have to be used (Figure 4a). In fact, an almost 50-fold increase in the
value of objective function is achieved by increasing d from 4 mm to 48 mm. At d =
56 mm a significant drop in F was obtained. In Table 1 the optimal parameters for dif-
ferent distances between the electrodes are presented, together with the calculated total
current through the model (I) and the volumes of reversibly and irreversibly electropo-
rated tissue (Vrev and Virr).
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with Figure 4b suggesting a linear relationship between the two. Positioning the elec-
trodes so that the electric field is perpendicular to the direction of muscle fibers pro-
duces objective functions up to 20% higher than the parallel orientation (Figure 4c),
however slightly higher voltages had to be used to achieve this.
Figure 4 Optimal values of the objective function depending on geometrical parameters for two
electrodes. Left axis: maximum values of obtained objective functions normalized by the absolute
maximum value of objective function obtained in the parametric study (F/Fmax); right axis: voltage
between electrodes (U) that leads to the maximum values. All the figures show optimal solutions for each
given value of the parameter shown on the horizontal axis, while the other parameters change in steps as
defined in caption of Figure 3 for two electrodes. F/Fmax is presented in dependence of: A) the distance
between electrodes - d, B) depth of electrode insertion - z and C) angle of electric field with respect to
muscle fiber orientation - j.
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function. At lower voltages increasing the voltage increases the objective function,
however after a peak is reached (1400 V) the objective function values start to sharply
decrease, because the damage to tissue exceeds the values (Vrev or I) tolerated by the
objective function.
Figure 5 Optimal values of the objective function depending on voltage between electrodes for
two electrodes. Left axis: maximum values of obtained objective functions normalized by the absolute
maximum value of objective function obtained in the parametric study (F/Fmax); right axis: average volume
of irreversible electroporation obtained by using those voltages (Virr). The figure shows optimal solutions for
given values of U, while the other parameters change in steps as defined in caption of Figure 3 for two
electrodes.
Figure 6 Optimal values of the objective function depending on geometrical parameters for six
electrodes. Left axis: maximum values of obtained objective functions normalized by the absolute
maximum value of objective function obtained in the parametric study (F/Fmax); right axis: voltages
between rows of electrodes (U) that lead to the maximum values. All the figures show optimal solutions
for each given value of the parameter shown on the horizontal axis, while the other parameters change in
steps as defined in caption of Figure 3 for six electrodes. F/Fmax is presented in dependence of: A) the
distance between rows of electrodes - d, B) distance between electrode in a row - b, C) depth of electrode
insertion - z and D) angle of electric field with respect to muscle fiber orientation - j.
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When we analyzed solutions for six electrodes (Figure 6) similar results were obtained
as for two electrodes. Increasing the distances between electrodes and depth of inser-
tion leads to higher values of the objective function and demands higher voltages (Fig-
ure 6a, c). Table 2 shows how changing the distance between the electrode rows
affects the other parameters needed to achieve the highest values of the objective func-
tion and Vrev. Increasing the distance between electrodes in a row (b)a l s op r o d u c e s
some effect, but mainly only between positioning the electrodes very close together or
very far apart (Figure 6b). Furthermore, we obtained a significant effect of the electric
field orientation on the quality of the solution. Positioning the electrode perpendicu-
larly to the direction of muscle fiber (j = 90°) produced solution with twice higher
values of the objective function (Figure 6d) compared to parallel orientation of the
electrodes (j =0 ° ).
Figure 7 shows how increasing the voltage between the electrode rows affects the
objective function: at lower voltages increasing the voltage increases the objective func-
tion, however after the maximum is reached (1400 V) the objective function values
sharply decrease.
Table 1 Optimum gene electrotransfer parameters (z, j, U) for two electrodes
d [mm] z [mm] j [°] U [V] I [A] Vrev [cm
3] Virr [cm
3]
4 20 90 600 26.4 1.2 0.2
8 10 90 800 13.0 4.4 1.0
16 30 90 1000 7.5 8.7 0.9
24 40 90 1000 15.0 28.7 1.0
32 40 90 1000 16.6 36.2 0.7
40 40 90 1200 18.4 46.9 0.8
48 40 90 1400 18.4 51.5 0.9
56 40 0 1000 18.9 43.4 0.8
Calculated values of I, Vrev,V irr >determined by the parametric study for different distances between electrodes (d).
Figure 7 Optimal values of the objective function depending on voltage between electrodes for six
electrodes. - Left axis: maximum values of obtained objective functions normalized by the absolute
maximum value of objective function obtained in the parametric study (F/Fmax); right axis: average volume
of irreversible electroporation obtained by using those voltages (Virr). The figure shows optimal solutions for
given values of U, while the other parameters change in steps as defined in caption of Figure 3 for six
electrodes.
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The optimization results for two electrodes are presented in Figure 8 for 4 sequences
of the calculation, taking into account the changes in conductivity during electropora-
tion. The first sequence (Figure 8A), which matches the calculation performed with a
static model of electroporation (no changes in conductivity), shows that at the begin-
ning of the electric pulse the volume of reversibly electroporation (black contour in
Table 2 Optimum gene electrotransfer parameters (b, z, j, U) for six electrodes.
d [mm] b [mm] z [mm] j [°] U [V] I [A] Vrev [cm
3] Virr [cm
3]
4 8 30 90 200 23.3 3.7 0.1
8 24 20 90 400 18.1 12.0 0.1
16 24 40 90 600 29.6 49.0 0.8
24 24 40 90 800 29.9 76.5 0.8
32 16 40 90 1000 28.5 87.5 0.7
40 16 40 90 1200 29.8 114.6 0.8
48 24 30 90 1400 27.4 130.6 0.9
56 28 40 90 1400 28.5 158.9 0.6
Calculated values of I, Vrev,V irr determined by the parametric study for different distances between electrodes (d).
Figure 8 Four steps of the sequential analysis (A-D) of the electroporation process for two
electrodes. The optimum parameters as determined by the genetic algorithm were: d = 56 mm, z=4 0
mm, j = 90°, U = 1550 V. The electric field distribution is shown for a plane perpendicular to electrode
insertion 2 cm deep in muscle tissue. The black contour represents the muscle area that has been
reversibly electroporated, i.e. area where the conductivity values have changed according to (3). Due to
ratio problems, the contour for irreversibly electroporated muscle tissue is left out of the figure; however it
is approximately the same as the dark red coloration surrounding the electrodes in sequence D.
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can see that the increase of conductivity due to electroporation extends the higher
electric fields towards the area in the center between the electrodes, resulting in much
larger volumes of reversibly electroporated muscle tissue (26 cm
3 vs. 81 cm
3). This
results in a very large volume of reversible electroporation and a much lower volume
of irreversible electroporation (0.9 cm
3). It is somewhat surprising that the perpendicu-
lar direction of the electric field produced better results, since the threshold for elec-
troporation is higher in this direction and therefore lower volumes would be expected.
This can be explained by a much higher current that is generated by the field parallel
to muscle fiber direction (conductivity is higher in that direction), thus the limitation
for electric current (30 A) set in the objective function are exceeded earlier for the par-
allel direction.
The optimization results for six electrodes are presented in Figure 9. In this case, the
perpendicular orientation produced almost two times better results than the parallel
orientation. Similarly as for two electrodes, the sequence of images in Figure 9 shows,
how taking into account the changes in conductivity during electroporation increases
Figure 9 Four steps of the sequential analysis (A-D) of the electroporation process for six
electrodes. The optimum parameters as determined by the genetic algorithm were: d = 56 mm, b=2 8
mm, z = 40 mm, j = 90°, U = 1350 V. The electric field distribution is shown for a plane perpendicular to
electrode insertion 2 cm deep in muscle tissue. The black contour represents the muscle area that has
been reversibly electroporated, i.e. area where the conductivity values have changed according to (3). Due
to ratio problem, the contour for irreversibly electroporated muscle tissue is left out of the figure, however
it is approximately the same as the dark red coloration surrounding the electrodes in sequence D.
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increases with consecutive steps we obtained that it is a highly non-linear function
where in the first step the biggest increase occurs; for two electrodes the increase is
2.5 times after the first step and 3.1 times at the final sequence; for six electrodes the
increase in Vrev after the first step is 2.9 times and 3.1 at the end of the sequence. The
changes in Virr are negligible due to limitation of Virr <1c m
3.
The difference between the perpendicular and parallel orientation can be illustrated
by using the same parameters as determined for optimal solution shown in Figure 9,
but by changing the direction of the generated electric field so that it is aligned with
muscle fibers (j =0 ° ). In this case, even more muscle volume becomes reversibly elec-
troporated, however at the same time, the current flowing through the tissue (80.5 A)
is much higher than the allowed current (30A) and also much higher compared to the
current for the perpendicular orientation (29.1 A). Also approximately three times
more tissue is irreversibly electroporated for parallel compared to perpendicular orien-
tation (Figure 10).
Discussion
Gene electrotransfer is already successfully being used for pDNA delivery in clinical
applications, such as gene therapy and DNA vaccination. However, achieving an ade-
quate extent of electroporation in target tissues can be difficult and requires extensive
experimentation. Numerical modeling of electroporation can be used to complement
in vivo experimentation as it allows planning of the electric field distribution before-
hand. In this study we used 3D numerical modeling of muscle tissue, parameterization
Figure 10 The last step of the sequential analysis of the electroporation process for six electrodes.
The same parameters as in Figure 9 were used, except for j =0 ° . The electric field distribution is shown
for a plane perpendicular to electrode insertion 2 cm deep in muscle tissue. The black contour represents
the muscle area that has been reversibly electroporated, i.e. area where the conductivity values have
changed according to (3). Due to ratio problem, the contour for irreversibly electroporated muscle tissue is
left out of the figure; however it is approximately the same as the dark red coloration surrounding the
electrodes.
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trical parameters on the distribution of electric field in muscle tissue and the optimum
parameters for gene electrotransfer in muscle tissue.
In the first part of this work we performed a parametric study to determine how var-
ious parameters affect the electric field distribution and volumes of tissue exposed to
only reversible electric fields in muscle tissue, which is a prerequisite for effective gene
electrotransfer. We determined that for large distances between the electrodes (d)a n d
for placing the electrodes deeper into the muscle (z), the volumes of reversibly electro-
porated tissue (Vrev) increases. However, concurrently the volume of irreversibly elec-
troporated tissue (Virr) and total current through the tissue (I)a l s oi n c r e a s e( s e e
Tables 1 and 2, and Figures 4 and 6). Increases in Virr and I can be explained with
higher voltage needed to reach the optimal electric field distribution at given d (Figures
4a and 6a), while for deeper insertion (larger z) Virr and I increase due to a larger sur-
face area of the electrodes in the tissue. For two electrodes the limiting factor is Virr,
which increases over the limit of 1 cm
3 if voltage over 1600 V is used. For six electro-
des I increases over 30 A before Virr gets over 1 cm
3 and I can therefore be considered
the limiting factor. Obviously, by choosing a different objective functions with different
limit for Virr and I it is possible to control their importance and thereby adjust the
results accordingly to the application and equipment used. The distance between the
electrodes in a row (b) for six electrodes does not have much effect on Vrev or Virr,
except at very small distances b, which, as expected is not optimal since three electro-
des with the same electric potential positioned very closely produce an electric field
very similar to the one of only one electrode. The advantages of having several electro-
des are therefore lost at small distances b.
When analyzing the effect of electrode orientation with respect to muscle fibers, we
obtained that the perpendicular orientation of the electrodes (j =9 0 ° )i sb e t t e rt h a n
for the parallel orientation (j = 0°) (Tables 1 and 2), since coverage of larger volumes
of tissue with electric field above Erev and below Eirr can be obtained. This can be
mostly explained by the smaller volumes of irreversible electroporation achieved in the
perpendicular orientation, whil ea tt h es a m et i m et h ec u r r e n t( I)f l o w i n ga l o n gt h e
muscle fibers in the parallel orientations is much higher, therefore the current limita-
tion of the objective function is achieved for lower voltages in the parallel orientation.
The perpendicular orientation is significantly better for six needle electrodes (F⊥ ≈ 2×
F||) while for two needle electro d e st h ed i f f e r e n c ei sn o tt h a tl a r g e( 2 0 % ) .T h i si si n
agreement with the in vivo study in mice, where no statistical difference in gene
expression was obtained between the perpendicular and parallel orientation for two
needle electrodes [34]. If possible, however, it is best to switch orientation of the elec-
tric field during the application of electric pulses for more effective gene electrotrans-
fer, as already shown in several studies [46,77,78].
Furthermore, we analyzed the voltage dependence of the optimal solutions F(U)i n
parallel with the volume of irreversibly electroporated tissue Virr(U). We obtained that
by increasing the applied voltage the volume of only reversibly electroporated tissue
increased until an optimal voltage for a given electrode configuration was achieved
(Figures 5 and 7). A further increase in the applied voltage lead to excessive tissue
damage (large Virr) and sharp decrease in the objective function value F.T h i ss t r o n g
dependency on pulse amplitude and relatively narrow window of pulse amplitudes for
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similarly transfection efficiency gradually increased above a threshold voltage, but
further increase in voltage lead to a decrease in transfection.
When the results of the parametric study are examined in details, some surprising
results can be seen. The relationship between the maximum objective function value
and different parameters is not always a smooth curve (e.g. Figure 6b). This is due to an
error introduced by relatively large discretization steps: as the objective functions were
only evaluated for discrete values of the analyzed parameters some good solutions were
missed. The discretization error is also responsible for a “strange” result for d = 56 mm,
where in contrast to all other best solutions the parallel orientation produced better
results than the perpendicular orientation. Also, for small distances d between the elec-
trodes, I becomes the major limiting factor and therefore Virr does not come even close
to the limiting value of 1 cm
3 set in the objective function. The reason for this seems to
be in the extreme non-linearity of the used model. Namely, for smaller electrode dis-
tances the electric currents get very high due to small resistance between the electrodes.
The parametric analysis enabled us to understand the relationship between different
parameters that can affect the electric field distribution and thus gene electrotransfer.
However, in order to optimize these parameters for a given clinical application (treat-
ment planning) such an exhaustive search of the parameter space would take too long
and demands very large computer resources. A better approach is, as already demon-
strated for electrochemotherapy [67,68] to directly apply an optimization algorithm to
determine the optimal parameters. In our study, optimization took only 1.2 hours com-
pared to 23 hours for the parametric study (for two electrodes) and 1.4 hours com-
pared to 4 days for six electrodes. In our optimization study we used the same
objective function as in the parametric study, only the parameter stepping was more
accurate (see Methods). Therefore, as expected the obtained optimal solutions differ
only slightly from the ones obtained in the parametric study (compare Figures 8 and 9
with Tables 1 and 2). This difference can be attributed to a smaller discretization step
used in the optimization.
The electric field distributions of the optimal solutions are presented in Figure 8
(two electrodes) and Figure 9 (six electrodes). It can be seen that taking into account
dynamic changes of conductivity during electroporation (sequential analysis) has a sub-
stantial effect on the final electric field distribution and Vrev. Namely, in the first
sequence only a small volume of muscle tissue is reversibly electroporated; while in the
final sequence the whole volume between the electrodes reaches E> E rev (compare Fig-
ures 8a, b, c and 8d). This effect is more pronounced for six electrodes (Figures 9a, b,
c and 9d). An array of six electrodes also provides a better electric field distribution
overall, with higher objective function values (F6 ≈ 3×F 2). These results agree with
our previous studies of optimization for electrochemotherapy [59,66] that more elec-
trodes enable coverage of larger volumes of tissue with a more homogeneous field. Six
electrodes probably represent a good compromise between optimal electric field distri-
butions and still keeping the invasiveness of the procedure relatively low. Nevertheless,
using two electrodes can also produce good results, if parameters are select appropri-
ately as already demonstrated [34,80,81].
The objective function used in our study was chosen according to the prerequisite
for efficient gene electrotransfer: the cells should only be electroporated reversibly and
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observation that the volume of electrotransfected muscle tissue correlates with the
amount of expressed protein [45]. In several studies of gene electrotransfer it was
shown that larger transfected volumes are beneficial while for DNA vaccination the
transfected volume is probably not such a critical parameter [19]. The optimization
and proper selection of objective function has to be done for a specific application
together with researchers and physicians in clinics, based on complementary analysis
and evaluation of pain and other undesired effects, such as tissue inflammation or
thermal damage.
The presented analysis is partially similar to previous studies of optimization of para-
meters for electrochemotherapy [66-68] or irreversible ablation of tumors (IRE) [61,63]
where parameterization and/or optimization was also used to determine optimal elec-
troporation parameters. However, there are two very important differences between
our and the previous studies of ECT and IRE. Firstly, we included muscle anisotropy
and sequential analysis in our models which was never done before and has also
important effect on optimal solutions. Secondly, for ECT the objective function is set
so that the most important parameter (weight) is the coverage of the whole tumor
with E >Erev, while irreversible electroporation of the tumor is not severely penalized,
since the goal of the therapy is tumor death; in EGT, however, it is enough that target
tissue is just above the reversible electroporation threshold, while irreversible electro-
poration is not acceptable since it does not lead to expression of transfected genes. For
this reason the additional constrain of Virr was put into the objective function, which
penalizes solutions that would damage the tissue. For IRE a similarly reasoning would
lead to another choice of objective function. Another important difference between the
three applications is also what we want to treat: in ECT and IRE we want to treat a
well defined target tissue and avoidance of electroporating vital organs is crucial, while
for EGT of muscle tissue we want to reversibly electroporate large volumes.
In our numerical models joule heating was not analyzed as several studies have
already shown that heating due to short 100 μs is negligible [82,83]. Nevertheless, a
conservative estimation of the temperature after the electric pulses (see Figure 9 for
parameters used), where cooling of tissue due to heat conduction was not taken into
account, was below 46 °C in the vicinity of the electrodes and below 38°C in the center
between the electrodes, confirming that the proposed pulses would not cause extensive
thermal damage. Furthermore, in our case the 30 A limit for total current prevented
unwanted thermal damage. However, if longer trains of pulses were applied, e.g. 8 × 10
ms, thermal damage could become a the limiting factor that would have to be taken
into account in the objective function.
We analyzed two and six needle electrode configurations, while plate electrodes were
not analyzed since they cannot be applied for gene electrotransfer into muscle tissue in
large animals and humans [84,85]. Two needle electrodes were analyzed since they are
widely used in in vivo gene electrotransfer, while six electrodes were chosen as they
enable a more homogeneous electric field inside treated tissue and altogether more
optimal solutions. The relatively large electrode distances used in the study were used
to extent applicability of our results from small animals to large animals and humans.
One of the limitations of our numerical model is that it performs calculations on a
limited domain of muscle tissue and that no other tissues (e.g. skin) are included. This
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results. No significant variation of the results (less than 2%) was obtained if the size of
the model was increased for a factor of two. Also we have previously shown that if an
additional layer with much lower conductivity is added on the top surface (resembling
skin tissue) no significant effect is observed on the electric field distribution [66].
We further have to stress that the presented model and optimization was performed
for relatively short electric pulses (8 × 100 μs) since the thresholds Erev and Eirr are
relatively well defined [72]. In a variety of studies of in vivo gene electrotransfer it was
shown that different electric pulse parameters can be used for efficient transfection
[32]: 1) relatively short pulses of 6 × 100 μs [86]; 2) relatively long and low pulses, e.g.
8 × 20 ms [35,80,87-89]; and 3) combination of high-voltage and low-voltage pulses
[47,71,90-93]. To use the presented numerical optimization for different pulses, the
electroporation thresholds would have to be determined and built into the electropora-
tion models. The presented method of numerical modeling and optimization is generic
and can be applied to different electrode configurations (e.g. plate, hexagonal, multi-
array), electric pulse parameters (if thresholds Erev and Eirr are known), other tissues
(skin, liver, etc.) or performed for different definition of objective function defined on
the basis of specific needs of given electroporation-based clinical applications such as
gene therapy, DNA vaccination, electrochemotherapy or ablation by irreversible
electroporation.
The presented numerical study of gene electrotransfer is the first study that enables
optimization of electric parameters and electrode positions for gene electrotransfer in
vivo. Moreover, it takes into account anisotropy of muscle tissue as well as dynamic
changes of conductivity during electroporation by using sequential analysis. As such, it
presents the first attempt to optimize electric pulse parameters and electrode position-
ing for gene electrotransfer. Our results can be used as guidelines for researchers and
physicians in selecting optimal parameters for in vivo gene electrotransfer and thus
indirectly also reduce the number of animals used in clinical studies of gene therapy
and DNA vaccination.
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